SMITHS FALLS, ON, Nov. 28, 2019 /CNW/ – Tokyo Smoke, Canopy Growth Corporation’s (“Canopy Growth” or the “Company”) (TSX: WEED) (NYSE: CGC) award-winning retail subsidiary is proud to announce that after working closely with recently-announced Ontario retail license winners, it has entered into agreements with five retailers who have progressed to key, public stages in the licensing process.
In particular, three locations have been posted to the AGCO website and the two others have received official confirmation and will post the required on-site notice today prior to locations being posted online. Locations include:
390 Lakeshore Dr. Unit 3, North Bay, ON 75 Pinebush Road Unit D0005, Cambridge, ON 570 Bloor St. West, Toronto, ON 1303 Queen St. East, Toronto, ON 1082 Memorial Avenue, Thunder Bay, ON
“As a company, we are pleased to see this progress in the Ontario retail market,” said Mark Zekulin, CEO, Canopy Growth. “Increasing our presence in Toronto and for the first time north of the GTA is an important step to continuing the growth of the Tokyo Smoke brand and providing Ontarians with easy access to the education and high-quality cannabis retail experiences they seek.”
These locations are owned and operated by independent business owners with the support of Canopy Growth’s existing retail team to ensure a consistently high level of customer experience and product curation. Once all five retail stores are open, total Canopy retail banners across Canada will reach 32 with more planned throughout the calendar year 2020.
Management believes that increased retail stores in Ontario are essential to the overall success of the cannabis sector, and to migrating cannabis sales from the illicit to the regulated market. The Company applauds the recent progress in bringing new stores closer to the market and encourages an open license process to complement the existing licenses granted and in process.
About Canopy Growth Corporation Canopy Growth (TSX:WEED, NYSE:CGC) is world-leading diversified cannabis, hemp, and cannabis device company, offering distinct brands and curated cannabis varieties in dried, oil and Softgel capsule forms, as well as medical devices through Canopy Growth’s subsidiary, Storz & Bickel GMbH & Co. KG. From product and process innovation to market execution, Canopy Growth is driven by a passion for leadership and a commitment to building a world-class cannabis company one product, site and country at a time. Canopy Growth has operations in over a dozen countries across five continents.
Canopy Growth’s medical division, Spectrum Therapeutics is proudly dedicated to educating healthcare practitioners, conducting robust clinical research, and furthering the public’s understanding of cannabis, and has devoted millions of dollars toward cutting edge, commercializable research and IP development. Spectrum Therapeutics sells a range of full-spectrum products using its color-coded classification Spectrum system as well as single cannabinoid Dronabinol under the brand Bionorica Ethics.
Canopy Growth operates retail stores across Canada under its award-winning Tweed and Tokyo Smoke banners. Tweed is a globally recognized cannabis brand that has built a large and loyal following by focusing on quality products and meaningful customer relationships.
From our historic public listing on the Toronto Stock Exchange and New York Stock Exchange to our continued international expansion, pride in advancing shareholder value through leadership is engrained in all we do at Canopy Growth. Canopy Growth has established partnerships with leading sector names including cannabis icons Snoop Dogg and Seth Rogen, breeding legends DNA Genetics and Green House Seeds, and Fortune 500 alcohol leader Constellation Brands, to name but a few. Canopy Growth operates eleven licensed cannabis production sites with over 10.5 million square feet of production capacity, including over one million square feet of GMP certified production space. For more information visit www.canopygrowth.com